Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty
Journal:
Current Drug Targets
Volume:
4
Page:
613-618
Author(s):
Motokuni Aoki, Ryuichi Morishita and Toshio Ogihara
Proteasomes as Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
656-670
Author(s):
Marco Piccinini, Michael Mostert and Maria Teresa Rinaudo
Cardiac Gene Therapy: Therapeutic Potential and Current Progress
Journal:
Current Gene Therapy
Volume:
3
Page:
418-451
Author(s):
E. Kizana and I. E. Alexander
Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
452-467
Author(s):
Lily Wu and Makoto Sato
Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer
Structure and Functional Relationships of Hsp90
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
301-323
Author(s):
Chrisostomos Prodromou and Laurence H. Pearl
Genes and Proteins Governing the Cellular Sensitivity to HSP90 Inhibitors: A Mechanistic Perspective
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
331-341
Author(s):
Alison Maloney, Paul A. Clarke and Paul Workman
The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
349-358
Author(s):
Luke Whitesell, Rochelle Bagatell and Ryan Falsey
Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
377-383
Author(s):
Edward A. Sausville, Joseph E. Tomaszewski and Percy Ivy
The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
275-286
Author(s):
Charles L. Densmore